Alternatives to Mammoth Biosciences
Mammoth Biosciences is a Biotechnology tool: biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Mammoth Biosciences
- Website
CRISPR Therapeutics64BiotechnologyZug, Switzerland$547.0MBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
- Website
Editas Medicine42BiotechCambridge, United States$210.0MA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website
Integra Therapeutics54BiotechBarcelona, Spain$134.8MBiotech company developing next-generation gene writing tools for advanced therapies.
- SYSynthetic Biology Engineering3Biotechnology
Engineering custom biological systems for various applications.
- Website
Caspr BiotechBiotechBuenos Aires, ArgentinaHacking healthcare with CRISPR technology.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Vizgen61BiotechnologyWaltham, United States$169.5MSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
- Website
Quartzy60BiotechnologyHayward, USA$40.0MA vertically-integrated procurement platform for the life sciences industry.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
- Website ALAlithea Genomics50BiotechnologyZurich, Switzerland$11.1M
Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.
- Website
Immitra Bio48BiotechnologyZürich, Switzerland$2.6MScalable, one-time curative in-vivo gene editing therapies.
- Website TOTolemy Bio46BiotechnologyCambridge, United Kingdom$1.4M
AI-enabled technology for cell biology research and biopharma development.
- Website
NanoString Technologies31BiotechnologySeattle, United States$15.3MDeveloper of spatial biology tools for life sciences research, now part of Bruker Spatial Biology.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Abcam61BiotechnologyCambridge, United Kingdom$256.9MGlobal supplier of life science research tools, including antibodies, reagents, and assays.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Freenome59BiotechnologySouth San Francisco, USA$570.0MFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
- Website
Celerion59BiotechnologyLincoln, USA$45.0MA global leader in clinical pharmacology and bioanalytical sciences.
Showing the 20 closest matches. See the rest on the Mammoth Biosciences profile.
Compare Mammoth Biosciences head to head
Side by side on what each one does, what it costs, and what real users report.